Corporate news

01.03.2024
Marinomed Biotech AG: Lucia Ziegler new Head of Investor & Public Relations
14.02.2024
Marinomed Biotech AG announces preliminary revenue for 2023
07.02.2024
Marinomed Biotech AG with important progress for Carragelose in 2024
18.12.2023
Marinomed Biotech AG evaluates strategic options for Carragelose portfolio
Lucia Ziegler, MSc
Head of Investor & Public Relations
Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg, Austria
+43 2262 90300
office@marinomed.com